These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35862238)

  • 1. Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis.
    Ivany E; Ritchie LA; Lip GYH; Lotto RR; Werring DJ; Lane DA
    Stroke; 2022 Oct; 53(10):3035-3046. PubMed ID: 35862238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants versus Warfarin in Patients with Atrial Fibrillation and Previous Stroke: A Systematic Review and Meta-Analysis.
    Shi M; Liu L; Wafa H; Curcin V; Wang Y
    Neuroepidemiology; 2024; 58(1):1-14. PubMed ID: 37848006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation medication in nontraumatic intracranial hemorrhage survivors with atrial fibrillation.
    Wang X; Wen D; Chen Y; You C; Ma L
    J Thromb Thrombolysis; 2023 Jul; 56(1):1-11. PubMed ID: 37022508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials.
    Ntaios G; Papavasileiou V; Diener HC; Makaritsis K; Michel P
    Int J Stroke; 2017 Aug; 12(6):589-596. PubMed ID: 28730948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial Fibrillation.
    Lin SY; Chang YC; Lin FJ; Tang SC; Dong YH; Wang CC
    J Am Heart Assoc; 2022 Mar; 11(6):e022849. PubMed ID: 35243876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriate doses of non-vitamin K antagonist oral anticoagulants in high-risk subgroups with atrial fibrillation: Systematic review and meta-analysis.
    Kim IS; Kim HJ; Kim TH; Uhm JS; Joung B; Lee MH; Pak HN
    J Cardiol; 2018 Oct; 72(4):284-291. PubMed ID: 29706404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral anticoagulation therapy in atrial fibrillation patients with a history of intracranial hemorrhage: a systematic review and meta-analysis.
    Liu M; Hou Y; Liu W; Liu M
    Ann Palliat Med; 2022 Oct; 11(10):3063-3074. PubMed ID: 35948473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
    Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
    JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Proietti M; Romanazzi I; Romiti GF; Farcomeni A; Lip GYH
    Stroke; 2018 Jan; 49(1):98-106. PubMed ID: 29167388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea.
    Lee MY; Han S; Bang OY; On YK; Jang SW; Han S; Ryu J; Park YJ; Kang S; Suh HS; Kim YH
    Adv Ther; 2022 Jul; 39(7):3112-3130. PubMed ID: 35524839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
    Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Ntaios G; Papavasileiou V; Makaritsis K; Vemmos K; Michel P; Lip GYH
    Stroke; 2017 Sep; 48(9):2494-2503. PubMed ID: 28716982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials.
    Al-Shahi Salman R; Stephen J; Tierney JF; Lewis SC; Newby DE; Parry-Jones AR; White PM; Connolly SJ; Benavente OR; Dowlatshahi D; Cordonnier C; Viscoli CM; Sheth KN; Kamel H; Veltkamp R; Larsen KT; Hofmeijer J; Kerkhoff H; Schreuder FHBM; Shoamanesh A; Klijn CJM; van der Worp HB;
    Lancet Neurol; 2023 Dec; 22(12):1140-1149. PubMed ID: 37839434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage.
    Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GYH; Larsen TB
    Stroke; 2019 Apr; 50(4):939-946. PubMed ID: 30869568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis.
    Kuno T; Takagi H; Ando T; Sugiyama T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Briasoulis A; Burger A; Bangalore S
    J Am Coll Cardiol; 2020 Jan; 75(3):273-285. PubMed ID: 31976865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of anticoagulation in atrial fibrillation patients with intracranial hemorrhage: A systematic review and meta-analysis.
    Zhou Q; Liu X; Yang X; Huang XH; Wu YZ; Tao YY; Wei M
    Front Pharmacol; 2023; 14():1122564. PubMed ID: 36969833
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimal use of antithrombotic agents in ischemic stroke with atrial fibrillation and large artery atherosclerosis.
    Kim TJ; Lee JS; Yoon JS; Oh MS; Kim JW; Park SH; Jung KH; Kim HY; Kwon JH; Choi HY; Kim HY; Eah KY; Han SW; Oh HG; Kim YJ; Shin BS; Kim CH; Kim CK; Park JM; Lee KB; Park TH; Lee J; Park MS; Choi JC; Kim C; Shin DI; Lee SJ; Kim DE; Cha JK; Kim EG; Yu KH; Hong KS; Lee YS; Lee JH; Sohn SI; Bae HJ; Lee YB; Lee JH; Rha JH; Lee BC; Chang DI; Ko SB; Yoon BW
    Int J Stroke; 2023 Aug; 18(7):812-820. PubMed ID: 36748980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation.
    Graham DJ; Baro E; Zhang R; Liao J; Wernecke M; Reichman ME; Hu M; Illoh O; Wei Y; Goulding MR; Chillarige Y; Southworth MR; MaCurdy TE; Kelman JA
    Am J Med; 2019 May; 132(5):596-604.e11. PubMed ID: 30639551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Anticoagulant Agents in Patients With Atrial Fibrillation and CKD: A Systematic Review and Pairwise Network Meta-analysis.
    Su X; Yan B; Wang L; Lv J; Cheng H; Chen Y
    Am J Kidney Dis; 2021 Nov; 78(5):678-689.e1. PubMed ID: 33872690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.